Photo taken from: Institute of Cancer and Crisis / LinkedIn
Jul 17, 2023, 09:31
Heteroleptic bipyridine PdII-Bian complexes were cytotoxic in a low micromolar concentration range and demonstrated some selectivity toward cancer cells compared to noncancerous MRC-5 lung fibroblasts – Jemma Arakelyan
I am happy to share that the American Chemical Society (ACS) published our recent research work, where we showed that heteroleptic bipyridine PdII-Bian complexes were cytotoxic in a low micromolar concentration range and demonstrated some selectivity toward cancer cells compared to noncancerous MRC-5 lung fibroblasts. Moreover, we did additional mechanistic studies to prove the potential role of DNA damage and reactive oxygen species production (ROS) in their anticancer activity.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 18:02
Dec 22, 2024, 17:54
Dec 22, 2024, 17:51
Dec 22, 2024, 17:47
Dec 22, 2024, 17:44
Dec 22, 2024, 17:39
Dec 22, 2024, 17:36
Dec 22, 2024, 17:32
Dec 22, 2024, 17:18